1. 1) O’Brien, J. S.; Sampson E. L. Fatty acid and fatty aldehyde composition of the major brain lipids in normal human gray matter, white matter, and myelin. J. Lipid Res. 6 (4), 545-551 (1965).
2. 2) Sargent, J. R.; Coupland, K.; Wilson, R. Nervonic acid and demyelinating disease. Med. Hypotheses 42 (4), 237-242 (1994).
3. 3) Tanaka, K.; Shimizu, T.; Ohtsuka, Y.; Yamashiro, Y.; Oshida, K. Early dietary treatments with Lorenzo’s oil and docosahexaenoic acid for neurological development in a case with Zellweger syndrome. Brain Dev. 29 (9), 586-589 (2007).
4. 4) Coupland, K.; Raoul, Y. Nervonic acid derivatives, their preparation and use. U. S. Patent 6,664,406 (2003).
5. 5) Coupland, K. Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use. U. S. Patent 6,956,059 (2005).